Thermo Fisher Scientific Gibco CTS OpTmizer Pro Serum Free Media (SFM)

Wednesday, 10 February, 2021 | Supplied by: Thermo Fisher Scientific


Thermo Fisher Scientific has developed a medium for the development and expansion of human T lymphocytes (T cells) for cell therapy developers using allogeneic workflows. The Gibco CTS OpTmizer Pro Serum Free Media (SFM) is a media solution that targets the metabolism of healthy donor cells, making it suitable for use in the production of allogeneic, off-the-shelf cell therapies.

In contrast to autologous cell therapies, which are produced using a patient’s own cells, allogeneic cell therapies are derived from healthy donor tissue, potentially enabling more scalable cell therapy manufacturing. The SFM enhances donor T cell proliferation, maintains central memory T cells further into expansion and delays effector differentiation of healthy donor T cells, resulting in fast production of central memory cells.

The product packaging is suitable for closed systems and is manufactured in conformity with current Good Manufacturing Practice (cGMP) standards. The serum-free media is ready to use and compatible with automated and long workflows, providing a consistent formulation designed to maintain cell quality and increase the efficacy of cell-based therapies.

Online: thermofisher.com
Phone: 1300 735 292
Related Products

Merck ColorWheel flow cytometry antibodies and dyes

The portfolio allows users to independently select antibodies and dyes for assembly in any...

Matreya antibodies directed against ganglioside and globoside glycolipids

Matreya has a range of monoclonal and polyclonal antibodies directed against the carbohydrate...

Affinity Biosciences phospho-specific antibodies

Affinity Biosciences is an original manufacturer of phospho-specific antibodies, offering over...


  • All content Copyright © 2021 Westwick-Farrow Pty Ltd